The term sinus histiocytosis with massive lyrnphadenopathy (SHML) was introduc ed by Rosai and Dorfinan in 1969. Although SHML was initially described as low-pain cerv ical lymphadenopathy accompanied by fevet; leukocy tosis, an increased erythrocyte sedim entation rate, and hypergammaglobulinemia, extranodal involvement is observed in 25 to 40% of cases. This pathology is velY rare and involvement of the nasal fossae and paranasal sinus es is exceptional. We present two atypical cases of extranodal involvement exelusively confined to the head and review the literature. The first case showed a dramatic involvement offacial skin and tnuscles, orbit, and paranasal sim/ses. In the second case , the diseas e was limifed to the nasalfossae. Both cases showed exelusive extranodal involvement limit ed to the head region. In the absence oflymphadenopathy, diagnosing Rosai-Dorfman disease is dijJicult because ofthe lack ofthe most typical manifestation ofthe disease.
Introduction
In 1969, Rosai and Dorfman 1 described 4 cases of a disease they called sinus histiocytosis with massive lymphadenopathy (SHML). They referred to 2 previous cases described in the literature by Azoury and Reed (1966) 2 and by Vineent and Miercort (1967) . 3 In 1972, Rosai and Dorfman analyzed 30 additional cases, establishing SHML as a well-defined clinicopathologic entity."
Approximately 600 cases ofSHMLhave been described in the English literature, generally children oryoung adults with tumoral cervical adenopathy, fever, hypergammaglobulinemia, an increased erythrocyte sedimentation rate (ESR), and leukocytosis with neutrophilia. Other Iymphatic groups, such as mediastinal, axillary, and inguinallymph nodes , can also be affected. In about 40% of cases, one or more of the following extranodal sites are affected':
From the Department of Otorh inolaryngol ogy, Sao Paulo Universit y, Bra zil. Reprintrequests:Rafael Burihan Cahali, MD, RuaMacau232 , 04032-020 Säo-P aulo-Sf', Braz il. Phone: 55-11-55 79-1299; fax: 55-11-55 71-9320; e-mail : cahali@ig.com.br 844 eyelids, orbit , respiratory tract, salivary glands, skin, bone , testis , lung , kidney, central nervous system, thyroid , and gastrointestinal tract.v' Extranodal involvement is often responsible for the most important clinical manifestations of the disease. The cause of SHML has not been established, but two theories exist. One associates the disease with a specific infectious process; the other attributes it to a disturbance of the immune system. The course of the disease is generally benign, with spontaneous remission, but rare cases of death have been reported.?
In the absence of typical tumor Iymphadenopathy, the diagnosis ofSHML, or Rosai-Dorfrnan disease, is difficult. We report 2 patients we attended at the Otorhinolaryngology Department at the University of Säo Paulo between 1989 and 2001.
Case reports
Case 1. A white man reported rhinorrhea and nasal obstruction since 1980, which were diagnosed as bilateral chronic sinusitis and right nasal polyposis. In 1982, the patient underwent bilateral maxillary sinusectomy through a Caldwell-Luc technique and right nasal polypectomy, which led to temporary improvement. Symptoms recurred after 4 years , and the patient underwent the same surgery in 1986. In 1990, progressive bulging occurred in his eyelids and in the maxiliary, zygomatic, and bilateral masseteric regions.
In April 1991, we attended the patient for the first time. He was then 38 years old and presented with diffuse infiltration of the facial skin affecting the eyelids, mainly the right , which showed discrete exophthalmus (figure I). Rhinoscopy showed a polypoid lesion in the right middle meatus . Computed tomography (CT) and magnetic nuclear resonance imaging of the face and cranium revealed a marked heterogeneous increase in the anterior soft parts of the face . The masseter, pterygoid, and temporalis muscles, as weil as the eyelids and parotid glands , were also affected. The lesion was found to extend to the nasal fossae, maxillary sinuses, periorbital fat, and bilaterally to the extrinsic ocular musculature (figure 2).
Laboratory examination showed hypergammaglobu- Corticotherapy led to important regression of the facia l bulging, but beca use the patient suffere d from gastric ulcer, this therapy had to be disco ntinued. Therefore, in October 1991, we opted for surgieal excision of the lesion in the right side of the face . A large portion of a fibroe lastic tissue infiltrating all facial tissue without Iimits or dissection planes was resected. It was not possi ble to identify fat , fascia , or muscle tissue. The immediate result was highl y satisfactory; however, the surgical Figure 1 . Pre-(A) and postinfiltration (B) photograph s show the appearance of bed secre ted large amo unts ofa sero us fluid, the pati ent in Case 1. which impai red the adhesio n of the skin despite the use of a drain and compressive dressings . Treatment wit h high corticoid doses resu lted in secretion contro l and removal of the drain after attach ing the skin flap. However, 4 months after surgery and with discontinuation of the drug , the same bu lging observed initially occurred again in the right hem iface . Due to the lack of an effec tive trea tment and his intolerance to corticotherapy, the patient was kept under observation and to date has maintained a stable condi tion.
Case 2. An 18-year-old white man reported a prog ressive right nasal obstruction acco mpanied by frequent ipsilateral was compatible with Rosai-Dorfman disease.
One year after the first surgery, a simi lar lesion was found in the left nasa Ifossae . In February 1998, the patient underwent the same type of surgery, and the mass was removed from the septumoAnatomopathologic examination of the mass aga in revealed Rosai-Do rfman disease. Three years after the last surgery, the nasa I fossae are free of any mass and the patient remains asymptomatic.
Discussion
Approximate ly 600 cases of Rosa i-Dorfman disease have been reported in the literature. Their ana lysis shows a worldwide distribution of the disease, which predo minant ly affects whites (43.6 %).5The disease can man ifest in any age group, although 81% ofreported cases occurred during the first and second decades of life, and has a 2: I male-to-female ratio." Our patients were white males who reported the occurrence of the disease during the second and third decades of life.
The predominant clinical manifes tation ofthe disease is tumoral cervical adeno pathy (87.3 % ofcases) that, in most cases, is painless and bilatera l, affecting one or all cervical gang lion chains. Lymph nodes are isolated, mobi le, and small during the initial stages but become adherent with disease progression, forming a voluminous multinodu lar mass. The axi llary (23.7%), inguina l (25.7%), and mediastina l (14.5 %) regions can also be affected, but always to a lesser ext ent than cervical invo lvemen t.' Extranodal man ifestation of the disease is observed in 28 to 43% of cases , with preference for head and neck regions.v" The patients we stud ied presented with extranodal disease confined to head and neck regions. Nodal involvemen t was not observed, although noda l invo lvement may have occurred during an earlierphase. Feveroccurs in up to 30% of cases but was absent in our patients. In 85% of cases , patients with Rosai -Dorfman disease are in good general hea lth without significant symptoms of the disease.' Laboratory altera tions are frequent and includ e anemia (65.7%), leukocytosis (59 .1%) , neutrophilia (68.4 %) , increased ESR (88 .5%) , and hypergammaglobulinemia (90%) .5 Case I showed altered protei n concentration resulti ng from an increased gamma fractio n; Case 2 presented with only anemia.
In 1977, Sanchez et al" analyzed 113 cases and found involvement ofone or more extranodal sites in 28%. More recently, Foucar et al," in a review of 423 cases, observed extranodal involvement in 43%,but the authors emphasized that this value might have been overestimated because these cases attract greater interest forpublication.The most common sites ofext ranodal involvement are skin (27 .4%), nasa l and paranasal cavities (26 .8%), subcu taneo us tissue (20.2%), orbit and eyel ids (20.1%), and bone (18.4%).The concomitant invo lvemen t of one or more sites in the same individual is observed in up to 44.7 % of cases .
According to Foucar et al,'? the most frequent otorhinolaryngologic man ifest atio ns are found in the nasa l cavity (50%), followed by the pharynx (25%) , paranasal sinuses (18 .7%), amygdala (12.5 %), and trachea (6.3 %).Asecond extr anoda l site is involved in 68% ofthese patients. Case I showed invo lvement of the nasa l sinuses, parotid glands , subcutaneous facial skin , and orbit. In contrast, in Case 2, the disease affecte d only the nasa Icavity, as also described by Ozun lu et al."
With respee t to the orb it, the most commonly affected sites are the softtissue (84.6 %) and eyelids (45.5 %), which manifest as exophthalmus (53.8%), clo uding of vision , conjunctival infiltration , dip lopia, increased or reduced lacrimation, and slight ocular irritation." Case I showed palpe bral infiltration and involvement of the extrinsic musculature of the eye and orbita l fat, as we il as ocular irritation and altered visua l acuity.
The diagnosis of Rosai-Dorfman disease is made on the basis of clinical suspicion and confirmed by anatomopathologic examination. Histopathologic finding s include Iymphoid aggregates intercalated with areas cons isting ofhistiocytes, Iymphocytes, and plasm a cells and associated , or not, with vascular proliferat ion and fibrosis . These findings are less charac teristic in the extra noda l form of the disease .
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The epidemiologie, laboratory, and histologie findin gs are similar among patients with ganglionie and extranodal invo lvement, suggesting a common biolo gie basis. In genera l, extranoda l involvement does not determine a more aggressive eharaete r or poo rer outeome; howe ver, genera lized Iymphadenopathy, extranodal involvement of multiple organs (kidney, lungs, and liver), and immun ologie alterations lead to a poor prog nos is.?
The eause of the disease has not yet been established, but two theorie s exist. In the first theory, SHML is eaused by a spee ifie infeetious process based on the gen erally infeetiou s process seen at the onset of the disease (loealized adenop athy, fever, leukoeytosis with neutrophilia, inereased ESR, and hypergamm aglobulinemia) , whieh tend s to spontaneously regress after some time . How ever, no laboratory evidenee points to an etiologie agent.v" In the second theory, the disease is attributed to an abnonna l immun ologie response, beeause depression ofi mmunologie ee lls ean be observe d. However, no other clinieopathologie signs suggesting a defieient humoral or eellular immunity or phagoe ytosis disorders have been reported.S'v"
The c1 inieal and mieroseopie manifes tation of SHML should be differentiated from malignant Iymphoretieular neoplasias, such as Hodgkin 's disease and mo noey tie leukem ia, histioeytosis, rhinoscleroma, tubereulosis,j uve nile xanthogranuloma , dermatofibrom as, and eosinop hi lie gra nuloma , amo ng others . Depend ing on the site affeeted, other pathologies also need to be excluded.I'"! ?
The best treatment for Rosai-Dorfman disease has yet to be established. Some authors defend surgiea l treatm ent with partial or total resee tion, radiotherapy, ehemothera py, and antibiotie therapy. Kornp" reported the following treatments for 84 patient s: 39 underwent surgery beeau se of airwa y obstruetion, neurologie or oeular compressions, or severe deformation;34 were submitted to radioth erapy and 67 to ehemotherapy. However, the patient s' response to radiotherapy or ehemotherapy was unsatisfaetory.
In the present study, we opted for observation in Case I, beeause surgiea l reseetion was not benefieial and the patient did not tolerate eortieo therapy. In Case 2, surgery led to a satisfaetory result, probably beeause the disease was restrieted and limited and, to date, the patient has been free of sign s and symp toms of disease.
Conclusian
Extrano da l manifestations of Rosai-Dorfm an disease are rare and range from restrieted to highly extensive forms. A treatme nt has not yet been established, with surgieal exeision showi ng a poor outeome. Beeause the head region is the preferred site of the extrano da l form of the disease, otorhinolary ngologists and pathologists should always be aware of SHML in making a differe ntial diagnosis.
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